Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-terminally truncated HER-2/neu protein as a cancer prognostic indicator

N-terminally truncated HER-2/neu protein as a cancer prognostic indicator

US Patent 6541214 · Granted Apr 1, 2003

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of treating cancer by inhibition of p95HER-2 production2012
HER-2 binding antagonists2011
HER-2 binding antagonists2011
HER-2 binding antagonists2009
Compositions and methods for treating cancer by modulating HER-2 and EGF recepto2009
Compositions and methods for treating cancer by modulating HER-2 and EGF recepto2008
HER-2 binding antagonists2008
HER-2 binding antagonists2002